Revance Therapeutics, Inc.
Revance Therapeutics, Inc. (RVNC) is a publicly traded company in the Unknown sector. Across all available filings, 31 corporate insiders have executed 506 transactions totaling $34.1M, demonstrating a bearish sentiment with -$30.1M in net insider flow. The most recent transaction on Jun 30, 2024 involved a transaction of 1,000 shares valued at $2.2K.
RVNC Insider Activity Summary
Who Is Buying RVNC Stock?
No significant insider buying has been recorded for RVNC in the recent period.
Who Is Selling RVNC Stock?
No significant insider selling has been recorded for RVNC in the recent period.
Is Revance Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RVNC is bearish with an Insider Alignment Score of 6/100 and a net flow of -$30.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
RVNC Frequently Asked Questions
Understanding RVNC Insider Activity
Insider trading at Revance Therapeutics, Inc. (RVNC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 31 insiders are actively trading RVNC stock, having executed 506 transactions in the past 90 days. The most active insider is Mark J. Foley (Executive), who has made 37 transactions totaling $17.2M.
Related Tools
Track Revance Therapeutics, Inc. Insider Activity
Get notified when executives and directors at RVNC file new Form 4 transactions